Back to Browse Journals » Integrated Blood Pressure Control » Volume 4

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

Authors Cheryl L Laffer, Fernando Elijovich

Published Date January 2011 Volume 2011:4 Pages 1—5

DOI http://dx.doi.org/10.2147/IBPC.S6562

Published 19 January 2011

Cheryl L Laffer1, Fernando Elijovich2
1Section of Hypertension and Vascular Medicine, 2Division of General Internal Medicine, Department of Medicine, Texas A&M Health Sciences Center College of Medicine, Temple, TX USA

Abstract: Recent guidelines for the treatment of hypertension have focused on the need for multiple medications to get most patients to goal blood pressure (BP). Two to three different classes of antihypertensive agents are frequently required, increasing the risk of poor compliance with therapy. Hence, the guidelines have recommended starting with combination therapy in patients with BP that is over 20 mm Hg systolic or 10 mm Hg diastolic above goal. The latest advance in treatment regimen has been the development of triple-therapy combinations of an angiotensin receptor blocker, amlodipine, and hydrochlorothiazide. We review the pathophysiologic rationale for such a combination and the efficacy, safety, and tolerability of the first triple therapy that has become available: valsartan + amlodipine + hydrochlorothiazide. Finally, we suggest that use of triple therapy could improve the accuracy of diagnosing resistant hypertension, an increasingly prevalent and severe condition, by enhancing adherence to treatment and weeding out patients with pseudoresistance. This would allow for implementation of expensive and invasive workup only in those truly resistant patients in whom it is justified.

Keywords: combination therapy, compliance, hypertension control rates, resistant hypertension

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

New nonlinear multivariable model shows the relationship between central corneal thickness and HRTII topographic parameters in glaucoma patients

Dimitrios Kourkoutas, Gerasimos Georgopoulos, Antonios Maragos, et al

Clinical Ophthalmology 2009, 3:313-323

Published Date: 3 April 2009

Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

Alberto F Rubio-Guerra, David Castro-Serna, Cesar I Elizalde Barrera, et al

Integrated Blood Pressure Control 2009, 2:55-62

Published Date: 23 November 2009

The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial

Lai Yi Eliza Wong, Chun Kwok Wong, Ping Chung Leung, et al

Patient Preference and Adherence 2010, 4:223-229

Published Date: 7 July 2010

A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system

Eroglu E, Tiwari PM, Waffo AB, Miller ME, Vig K, Dennis VA, Singh SR

International Journal of Nanomedicine 2013, 8:1403-1415

Published Date: 11 April 2013

Cetuximab: its unique place in head and neck cancer treatment

Specenier P, Vermorken JB

Biologics: Targets and Therapy 2013, 7:77-90

Published Date: 15 April 2013

Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer

Shi J, Wang Z, Wang L, Wang H, Li L, Yu X, Zhang J, Ma R, Zhang Z

International Journal of Nanomedicine 2013, 8:1551-1562

Published Date: 19 April 2013